Interwest Venture Management Co
- SEC CIK
- 0001697720
- Latest filing
- Oct 20, 2023
EIGR holding history
Eiger BioPharmaceuticals, Inc. in every 13F filed by Interwest Venture Management Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EIGR overviewAll 13F holders of EIGRFull Q3 2023 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −560,990−100.0% | Sold out | Holders |
| Q3 2022 | 560,990 | $4.22M | 13.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 560,990 | $3.53M | 6.6% | 00.0% | Unchanged | Holders |
| Q1 2022 | 560,990 | $4.66M | 1.8% | −203,928−26.7% | Reduced | Holders |
| Q4 2021 | 764,918 | $3.97M | 2.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 764,918 | $5.11M | 2.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 764,918 | $6.52M | 2.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 764,918 | $6.77M | 1.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.